0 Comments
0 Shares
373 Views
0 Reviews
Search
Discover new people, create new connections and make new friends
-
Please log in to like, share and comment!
-
Advancing Cancer Diagnostics: How Growth Factor Detection Kits and Immunoassay Reagent Kits Are Shaping Modern MedicineThe accurate detection and quantification of growth factors have become fundamental to modern cancer diagnostics, enabling clinicians to identify biomarkers that inform diagnosis, prognosis, and treatment selection. Growth factor detection kits, particularly human EGF ELISA kits, have emerged as essential tools for measuring EGF levels in clinical samples, providing critical information for...0 Comments 0 Shares 393 Views 0 Reviews
-
Anatomic Pathology Market Growth Driven by Rising Cancer Diagnostics DemandPolaris Market Research has announced the latest report, namely Anatomic Pathology Market Share, Size, Trends, Industry Analysis Report, By Product; By Application (Disease Diagnosis, Drug Discovery and Development, Others); By End-Use (Hospitals, Research Laboratories, Diagnostic Laboratories, Others), By Region; Segment Forecast, 2022 - 2030, that examines the overall market condition...0 Comments 0 Shares 1K Views 0 Reviews
-
Brain Cancer Diagnostics Market to Hit USD 3.51 Bn by 2036: China Grows at 9.5% CAGR, Illumina in FocusThe global Brain Cancer Diagnostics Market is estimated at USD 1.82 billion in 2026 and is projected to reach USD 3.51 billion by 2036, expanding at a 6.8% CAGR, according to Fact.MR analysis. The market was valued at approximately USD 1.7 billion in 2025 and is expected to create an absolute dollar opportunity of USD 1.69 billion between 2026 and 2036. Demand is being shaped by expanding...0 Comments 0 Shares 45 Views 0 Reviews
-
Breast Cancer Diagnostics Market Growth, Outlook and Deep Study of Top Key Players Analysis By Fact.MRROCKVILLE, MD /Sept 17, 2026 – According to Fact.MR estimates, the breast cancer diagnostics market stood at USD 5,878.0 million in 2025. The market is projected to reach USD 6,389.41 million in 2026 and climb to USD 12,451.97 million by 2036, progressing at a CAGR of 6.9%. Absolute dollar growth of USD 6,063 million is expected over the 2026–2036 forecast period....0 Comments 0 Shares 202 Views 0 Reviews
-
Circulating Tumor DNA: Advancing Non-Invasive Cancer DiagnosticsCirculating tumor DNA has become a cornerstone of modern oncology, enabling non-invasive cancer diagnostics and real-time monitoring of tumor dynamics through liquid biopsy testing. Circulating tumor DNA analysis is a powerful tool in liquid biopsy, providing critical insights into tumor genetics, treatment response, and disease progression. The global market for non-invasive liquid...0 Comments 0 Shares 368 Views 0 Reviews
-
Global Melanoma Cancer Diagnostics Market Outlook: Key Trends, Growth Drivers, and Future OpportunitiesAccording to the latest report published by Data Bridge Market Research, the Melanoma Cancer Diagnostics Market CAGR Value The global melanoma cancer diagnostics market size was valued at USD 4.95 billion in 2024 and is expected to reach USD 8.64 billion by 2032, at a CAGR of 7.2% during the forecast period The large scale Melanoma Cancer Diagnostics...0 Comments 0 Shares 303 Views 0 Reviews
-
How Exosome-Based Diagnostics and Therapeutics Are Transforming Precision Medicine and Personalized Cancer TreatmentThe global exosome diagnostic and therapeutics market is expanding as healthcare providers, pharmaceutical companies, and research institutions invest in integrated diagnostic and therapeutic solutions to improve patient outcomes. The market was valued at USD 15.44 billion in 2024 and is projected to reach USD 63.2 billion by 2032, growing at a CAGR of 19.26%. The Exosome Diagnostic And...0 Comments 0 Shares 276 Views 0 Reviews
-
Liver Cancer Diagnostics Market Size, Trends Analysis and Forecast by 2030According to the latest report published by Data Bridge Market Research, the Liver Cancer Diagnostics Market The global liver cancer diagnostics market is expected to gain market growth in the forecast period of 2023 to 2030. Data Bridge Market Research analyses that the market is growing with a CAGR of 6.5% in the forecast period of 2023 to 2030 and is expected to reach USD 12,445.57...0 Comments 0 Shares 466 Views 0 Reviews
-
Lung Cancer Diagnostics Market: Key Growth Drivers, Challenges, and Competitive LandscapeNEWARK, Del., September 10, 2026 — The global Lung Cancer Diagnostics Market is entering a period of structural expansion as molecular testing, liquid biopsy, low-dose CT screening, and biomarker-driven treatment pathways reshape how lung cancer is detected and characterized. The market was valued at USD 13.30 billion in 2025, is projected to reach USD 14.30 billion in 2026, and is...0 Comments 0 Shares 220 Views 0 Reviews
-
Melanoma Molecular Diagnostics Market: Revolutionizing Skin Cancer Detection and TreatmentThe fight against melanoma, the deadliest form of skin cancer, is being revolutionized by advances in molecular diagnostics. These technologies are moving beyond traditional pathology to provide a deeper, genetic-level understanding of the disease, enabling earlier detection, more accurate prognoses, and personalized treatment strategies. The Melanoma Molecular Diagnostics Market is...0 Comments 0 Shares 298 Views 0 Reviews
-
Molecular Cancer Diagnostics: Advancing Precision Oncology for Pancreatic CancerMolecular cancer diagnostics have revolutionized the management of pancreatic cancer, offering a more precise and personalized approach to diagnosis and treatment. Molecular cancer diagnostics utilize advanced technologies to detect pancreatic cancer biomarkers, enabling precision oncology testing that guides targeted therapies. The global market for these diagnostics is projected to...0 Comments 0 Shares 302 Views 0 Reviews
-
Europe Prostate Cancer Devices Market Growing at 6.9% CAGR 2025-2030 ReportAccording to a new report from Intel Market Research, the Europe prostate cancer devices market was valued at USD 567.8 million in 2024 and is projected to grow from USD 605.0 million in 2025 to USD 845.6 million by 2030, exhibiting a robust CAGR of 6.9% during the forecast period (2025–2030). This growth is driven by an aging male population with a higher risk profile, continuous...0 Comments 0 Shares 2K Views 0 Reviews
-
Europe Prostate Cancer Devices Market Growing at 6.9% CAGR 2025-2030 ReportAccording to a new report from Intel Market Research, the Europe prostate cancer devices market was valued at USD 567.8 million in 2024 and is projected to grow from USD 605.0 million in 2025 to USD 845.6 million by 2030, exhibiting a robust CAGR of 6.9% during the forecast period (2025–2030). This growth is driven by an aging male population with a higher risk profile, continuous...0 Comments 0 Shares 2K Views 0 Reviews
-
Liquid Biopsy Market Value, Demand and Competitive Industry InsightsLiquid biopsy has emerged as a transformative technology in modern oncology and precision medicine. The growing demand for non-invasive diagnostic techniques, rising prevalence of cancer worldwide, and increasing adoption of personalized medicine are significantly contributing to market growth. Liquid biopsy enables the detection of cancer biomarkers through blood samples, eliminating the need...0 Comments 0 Shares 1K Views 0 Reviews
-
Lymphoma Treatment Market Growth Potential Driven by Advances in Cancer TherapeuticsThe lymphoma treatment market is witnessing significant growth as healthcare providers increasingly focus on improving outcomes for patients diagnosed with Hodgkin lymphoma and non-Hodgkin lymphoma. Rising cancer prevalence, advancements in oncology research, and the growing adoption of innovative treatment approaches are contributing to the expansion of the market. The development of targeted...0 Comments 0 Shares 1K Views 0 Reviews
-
Non-invasive Cancer Diagnostics Market Outlook Points to Broader Screening ApplicationsThe global non-invasive cancer diagnostics market was valued at USD 80.9 billion in 2025 and is expected to reach USD 85.8 billion in 2026. By 2033, the market is projected to expand to USD 139.1 billion, registering a 7.1% CAGR from 2026 to 2033. North America led the global market in 2025, accounting for a 41.2% revenue share. Market expansion is being supported by the rising...0 Comments 0 Shares 156 Views 0 Reviews
-
Precision Cancer Diagnostic Tests Market Advancements Improving Cancer Survival RatesThe global precision cancer diagnostic tests market is witnessing remarkable growth due to the increasing demand for personalized medicine, advancements in molecular diagnostics, and rising cancer prevalence worldwide. Precision cancer diagnostics play a critical role in identifying genetic mutations, biomarkers, and molecular characteristics of tumors, enabling healthcare providers to develop...0 Comments 0 Shares 1K Views 0 Reviews
-
Smart Biopsy Devices Market Research Report Featuring Strategic Industry Trends and InnovationsThe healthcare industry is increasingly focusing on precision diagnostics and early disease detection, driving the adoption of advanced biopsy technologies. Smart biopsy devices have emerged as a significant innovation in diagnostic medicine, offering enhanced accuracy, real-time guidance, and improved tissue sampling capabilities. These devices integrate advanced imaging, navigation systems,...0 Comments 0 Shares 869 Views 0 Reviews
More Results
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek